<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">791885</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2021.791885</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Computational Insights Into the Effects of the R190K and N121Q Mutations on the SARS-CoV-2 Spike Complex With Biliverdin</article-title>
<alt-title alt-title-type="left-running-head">Qu et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Computational Study SARS-CoV-2 Spike/Biliverdin</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Zhiyuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Kaihang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geng</surname>
<given-names>Xiaoju</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Bo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gao</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1198839/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, <addr-line>Xuzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Xuzhou Medical University Technology Transfer Center Co., Ltd., Xuzhou Medical University, <addr-line>Xuzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<corresp id="c001">&#x2a;Correspondence: Jian Gao, <email>gaojian@xzhmu.edu.cn</email>
</corresp>
<fn fn-type="other" id="fn1">
<label>
<bold>
<sup>&#x2020;</sup>
</bold>
</label>
<p>
<bold>ORCID:</bold> Jian Gao <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://orcid.org/0000-0001-6723-0490">orcid.org/0000-0001-6723-0490</ext-link>
</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Biological Modeling and Simulation, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/753659/overview">James Leland Olds</ext-link>, George Mason University, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1356015/overview">Lance Hellman</ext-link>, Nevada State College, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1398895/overview">Qiang Shao</ext-link>, Shanghai Institute of Materia Medica (CAS), China</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>791885</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Qu, Li, Geng, Huang and Gao.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Qu, Li, Geng, Huang and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>The SARS-CoV-2 spike has been regarded as the main target of antibody design against COVID-19. Two single-site mutations, R190K and N121Q, were deemed to weaken the binding affinity of biliverdin although the underlying molecular mechanism is still unknown. Meanwhile, the effect of the two mutations on the conformational changes of &#x201c;lip&#x201d; and &#x201c;gate&#x201d; loops was also elusive. Thus, molecular dynamics simulation and molecular mechanics/generalized Born surface area (MM/GBSA) free energy calculation were conducted on the wild-type and two other SARS-CoV-2 spike mutants. Our simulations indicated that the R190K mutation causes Lys190 to form six hydrogen bonds, guided by Asn99 and Ile101, which brings Lys190 closer to Arg102 and Asn121, thereby weakening the interaction energy between biliverdin and Ile101 as well as Lys190. For the N121Q mutation, Gln121 still maintained a hydrogen bond with biliverdin; nevertheless, the overall binding mode deviated significantly under the reversal of the side chain of Phe175. Moreover, the two mutants would stabilize the lip loop, which would restrain the meaningful upward movement of the lip. In addition, N121Q significantly promoted the gate loop deviating to the biliverdin binding site and compressed the site. This work would be useful in understanding the dynamics binding biliverdin to the SARS-CoV-2&#x20;spike.</p>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2 spike</kwd>
<kwd>biliverdin</kwd>
<kwd>molecular dynamics simulation</kwd>
<kwd>MM/GBSA calculation</kwd>
<kwd>mutation</kwd>
</kwd-group>
<contract-sponsor id="cn001">Natural Science Foundation of Jiangsu Province<named-content content-type="fundref-id">10.13039/501100004608</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Six Talent Peaks Project in Jiangsu Province<named-content content-type="fundref-id">10.13039/501100010014</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Qinglan Project of Jiangsu Province of China<named-content content-type="fundref-id">10.13039/501100013088</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Since the advent of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), significant threats have been posed to the human population worldwide (<xref ref-type="bibr" rid="B25">Wang et&#x20;al., 2020</xref>). Millions of infections and deaths have been caused by this severe epidemic (<xref ref-type="bibr" rid="B11">Hu et&#x20;al., 2021</xref>). The spike protein trimers, a protruded structure that exists on the SARS-CoV-2 virions, are able to bind to a surface receptor on the cell and accommodate fusion of the viral and cellular membranes when they are glycosylated. For these reasons, with perfect conformational flexibility (<xref ref-type="bibr" rid="B13">Ke et&#x20;al., 2020</xref>), the SARS-CoV-2 spike is a crucial viral antigen and the target in designing antibodies, which lead to its support for the current critical SARS-CoV-2 vaccine development efforts (<xref ref-type="bibr" rid="B21">Tregoning et&#x20;al., 2020</xref>).</p>
<p>The previous study (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>) revealed that the SARS-CoV-2 spike could bind biliverdin (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>), the tetrapyrrole product of heme metabolism. The tetrapyrrole interaction pocket to the spike N-terminal domain (NTD)&#x2019;s deep cleft was mapped with the aid of cryo-electron microscopy and X-ray crystallography (<xref ref-type="bibr" rid="B5">Chi et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B16">Liu et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B27">Zost et&#x20;al., 2020</xref>). The relevance between mutations in the SARS-CoV-2 spike NTD and viral escape from antibody immunity (<xref ref-type="bibr" rid="B9">Graham et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B14">Kemp et&#x20;al., 2021</xref>) has been proven <italic>via</italic> observations in circulating viral strains (<xref ref-type="bibr" rid="B20">Tegally et&#x20;al., 2021</xref>). The reactivity of SARS-CoV-2 spike with immune sera was intensively decreased by biliverdin. Meanwhile, a subset of neutralizing antibodies was also inhibited by biliverdin. Characterized neutralizing antibodies primarily bind the spike C-terminal domain (referred to as the receptor-binding domain, RBD) (<xref ref-type="bibr" rid="B12">Ju et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B22">Walls et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B26">Wrapp et&#x20;al., 2020</xref>). The access to the dominant epitope of SARS-CoV-2 spike NTD can be controlled by an allosteric mechanism regulated through the recruitment of a metabolite.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(</bold>
<bold>A</bold>
<bold>)</bold> Molecular structure of biliverdin and <bold>(</bold>
<bold>B</bold>
<bold>)</bold> the crystal structure of the SARS-CoV-2 spike.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g001.tif"/>
</fig>
<p>After binding with biliverdin, a solvent-exposed loop &#x201c;gate&#x201d; in the wild type (WT) swings out of the way, allowing for Fab binding, which is complemented by an upward movement of a &#x3b2;-hairpin &#x201c;lip&#x201d; (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>) (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>). Moreover, the binding affinity of biliverdin bound to SARS-CoV-2 S1 is profoundly affected by the R190K and N121Q amino acid substitutions, with the corresponding K<sub>d</sub> values significantly weakening (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>). To our knowledge, the dynamic effects of the two mutations on the lip and the gate loops have not been illustrated yet. Furthermore, the sharp decreased molecular mechanism of biliverdin binding affinity, caused by the two mutations, is still unknown. Accordingly, a combined strategy of molecular dynamics (MD) simulation and molecular mechanics/generalized Born (GB) surface area (MM/GBSA) free energy calculation was conducted on the complexes of wild-type and two mutated SARS-CoV-2 S1 proteins in the present&#x20;study.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Construction of Simulation Systems</title>
<p>To figure out the impact of single-site mutations on the interactions of SARS-CoV-2 spike binding with biliverdin, three systems were constructed, including Spike<sup>WT</sup>/Biliverdin, Spike<sup>N121Q</sup>/Biliverdin, and Spike<sup>R190K</sup>/Biliverdin. In detail, the Spike<sup>WT</sup>/Biliverdin system was acquired from its corresponding X-ray crystal structure (PDB ID: 7b62), while the other two single-site mutations were constructed based on the system of Spike<sup>WT</sup>/Biliverdin in Sybyl-X2.1.</p>
</sec>
<sec id="s2-2">
<title>MD Simulation and MM/GBSA Free Energy Calculation</title>
<p>With the aid of AMBER 12 (<xref ref-type="bibr" rid="B2">Case et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B10">Han et&#x20;al., 2021</xref>) software, molecule energy minimization and MD simulation of the three systems were performed to reach the most stable conformation and decrease atomic energy. Some missing hydrogen atoms of the protein complex and ligand were added with the assistance of the tleap module in AMBER 12 software. The ligand biliverdin was minimized using the HF/6&#x2013;31&#x2a; optimization in the Gaussian 09 program (<xref ref-type="bibr" rid="B7">Frisch et&#x20;al., 2016</xref>). In AMBER 12 software, the electrostatic potentials, derived from the restrained electrostatic potential (RESP) fitting technique in the Gaussian program, created the partial charges. Generated by the antechamber module in AMBER 12 (<xref ref-type="bibr" rid="B23">Wang et&#x20;al., 2006</xref>), the field parameters and the partial charges for ligand biliverdin were established. The parameter for biliverdin was set by employing the general AMBER force field (GAFF) (<xref ref-type="bibr" rid="B24">Wang et&#x20;al., 2004</xref>), and the standard AMBER force field (ff03) (<xref ref-type="bibr" rid="B6">Duan et&#x20;al., 2003</xref>) was applied to define protein parameters in the following MD simulation.</p>
<p>Forming a rectangular box of TIP3P, the water molecules which extended 12&#xa0;&#xc5; away from any solute atoms wrapped up the three systems. Appropriate numbers of K<sup>&#x2b;</sup> were added to neutralize those systems. Every single system was initially energy minimized <italic>via</italic> three steps with the help of a sander module, as described in a previous study (<xref ref-type="bibr" rid="B3">Chen H. et&#x20;al., 2019</xref>). Then each system was heated gradually in the NVT ensemble from 0 to 300&#xa0;K in 100&#xa0;ps. Under a constant temperature of 300&#xa0;K, a 200&#xa0;ns MD simulation with a 2.0&#xa0;fs time step was carried out for each system. Also, the SHAKE procedure was used to restrict all bonds involving at least one hydrogen atom. The particle mesh Ewald (PME) was used to deal with long-range electrostatic interactions. Concerning the following binding free energy calculation, the coordinates were saved every 100&#xa0;ps in the sampling process.</p>
<p>With the aim of calculating the binding free energy, the calculation of MM/GBSA was carried out by using MM/GBSA in AMBER 12 software <italic>via</italic> the following equation (<xref ref-type="bibr" rid="B15">Kollman et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B4">Chen Q. et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B1">An et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B19">Shi et&#x20;al., 2021</xref>)<italic>.</italic>
<disp-formula id="equ1">
<mml:math id="m1">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">bind</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">complex</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">protein</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">ligand</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">MM</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">GB</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">SA</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>&#x394;</mml:mi>
<mml:mi>S</mml:mi>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">vdw</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">ele</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">GB</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>&#x394;</mml:mi>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">SA</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>&#x394;</mml:mi>
<mml:mi>S</mml:mi>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
</disp-formula>
</p>
<p>&#x394;<italic>E</italic>
<sub>MM</sub>, the gas-phase interaction energy, is composed of two components: &#x394;<italic>E</italic>
<sub>vdw</sub> (van der Waals energy) and &#x394;E<sub>ele</sub> (electrostatic energy) (<xref ref-type="bibr" rid="B8">Genheden and Ryde, 2015</xref>). Both &#x394;<italic>G</italic>
<sub>GB</sub> and &#x394;<italic>G</italic>
<sub>SA</sub> mean the components of the desolvation free energy. While the former is polar, the latter one is nonpolar. The polar desolvation free energy, with dielectric constants of the solvent and the solute set to 80 and 1, respectively, was calculated by the GB models developed by Onufriev et&#x20;al. (<xref ref-type="bibr" rid="B17">2004</xref>). Normal-mode analysis was applied in evaluating the entropy contribution to the binding free energy.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<sec id="s3-1">
<title>Overall Structure and Dynamics</title>
<p>The root mean square deviation (RMSD) values of the whole protein backbone atoms were calculated to explore the conformation stability of three systems during the 200&#xa0;ns MD simulation (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>). The plot shows that all three systems reached equilibrium after 100&#xa0;ns. The RMSD values of the Spike<sup>WT</sup>/Biliverdin and Spike<sup>N121Q</sup>/Biliverdin are around 3&#xa0;&#xc5;, while that of the Spike<sup>R190K</sup>/Biliverdin mutation is around 4&#xa0;&#xc5; (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Two single-site mutations do not induce significant conformation change to the protein since the RMSD values of two mutated systems stabilize in a very short time. The previous study [5] revealed that the SARS-CoV-2 spike contains the motion of loop regions including &#x201c;gate&#x201d; (residues 174&#x2013;188) and &#x201c;lip&#x201d; (residues 143&#x2013;155). To further assess the dynamic changes of two regions, the same RMSD calculation was conducted. Compared with the lip loop (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>), residues in the gate take on intensively small volatility and maintain a lower RMSD value, mostly below 1.0&#xa0;&#xc5; (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). It is noticeable that Spike<sup>R190K</sup>/Biliverdin fluctuates in both regions while Spike<sup>WT</sup>/Biliverdin and Spike<sup>N121Q</sup>/Biliverdin are quite stable. Three plots together proved that 200&#xa0;ns was enough for three systems to&#x20;relax.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(</bold>
<bold>A</bold>
<bold>)</bold> RMSD of the backbone atoms in the three systems relative to their single initial structures. <bold>(</bold>
<bold>B</bold>
<bold>)</bold> RMSD of the backbone atoms in the &#x201c;lip&#x201d; region. <bold>(</bold>
<bold>C</bold>
<bold>)</bold> RMSD of the backbone atoms in the &#x201c;gate&#x201d; region. <bold>(</bold>
<bold>D</bold>
<bold>
<bold>)</bold>
</bold> RMSF of the backbone atoms in the three systems relative to their respective initial structures in 100&#x2013;200&#xa0;ns.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g002.tif"/>
</fig>
<p>We also employed the root mean fluctuation (RMSF) calculation of every amino acid residue based on a 100&#x2013;200&#xa0;ns MD trajectory to study the fluctuation of individual residues on the SARS-CoV-2 spike (<xref ref-type="fig" rid="F2">Figure&#x20;2D</xref>). It can be clearly seen that the residues of Spike<sup>N121Q</sup>/Biliverdin and Spike<sup>R190K</sup>/Biliverdin have changed after comparative analysis. Especially at loop regions of the gate and lip, the amino acid residues of Spike<sup>N121Q</sup>/Biliverdin fluctuated less obviously than did those of Spike<sup>WT</sup>/Biliverdin and Spike<sup>R190K</sup>/Biliverdin in two regions. In line with the above RMSD analyses, Spike<sup>R190K</sup>/Biliverdin is the most unstable system as its RMSF value is much higher than the other two systems in most cases. However, for the lip loop as well as residues at positions 121 and 190, there is only a little difference in the fluctuation of the RMSF value in all three systems. Also, since the possible interaction with surrounding residues, the RMSF value of the gate loop in the Spike<sup>N121Q</sup>/Biliverdin is lower than those of the other two systems. In total, it is reasonable to carry out the following binding free energy calculation and free energy decomposition analysis based on the last 100&#xa0;ns trajectories.</p>
</sec>
<sec id="s3-2">
<title>Binding Free Energy Calculated by MM/GBSA</title>
<p>To analyze how the binding affinity between biliverdin and the SARS-CoV-2 spike is affected by two single-site mutations, MM/GBSA free energy calculation was conducted. According to <xref ref-type="table" rid="T1">Table&#x20;1</xref>, the binding free energy (&#x394;<italic>G</italic>
<sub>bind</sub>) of Spike<sup>WT</sup>/Biliverdin (&#x2212;18.60&#xa0;kcal/mol) is stronger than that of Spike<sup>R190K</sup>/Biliverdin (&#x2212;15.39&#xa0;kcal/mol), which is in line with the fact that the R190K mutant would increase the Km value from 9.8 to 1,500&#xa0;nM (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>). Unexpectedly, the calculated &#x394;<italic>G</italic>
<sub>bind</sub> of Spike<sup>N121Q</sup>/Biliverdin is &#x2212;18.45&#xa0;kcal/mol, comparable to the case of WT, which is different from the previous findings that the N121Q mutant is more sensitive to the binding interaction of biliverdin to SARS-CoV-2 spike (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>). With regard to the puzzling question, it will be discussed in the following binding mode analysis. Nevertheless, as for all three systems, the van der Waals interaction (&#x394;<italic>E</italic>
<sub>vdw</sub>) plays a crucial role in the total binding free energy. Since the electrostatic interaction (&#x394;<italic>E</italic>
<sub>ele</sub>) is completely counteracted by the polar desolvation energy (&#x394;<italic>G</italic>
<sub>GB</sub>), the net of electrostatic interactions (&#x394;<italic>E</italic>
<sub>ele</sub>&#xa0;&#x2b;&#xa0;&#x394;<italic>G</italic>
<sub>GB</sub>) is even unfavorable to the binding affinities. Additionally, the differences in entropy contribution (T&#x394;<italic>S</italic>) of the three systems are not obvious.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Binding free energies and individual energy terms of biliverdin in three systems calculated in MM/GBSA (kcal/mol).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">System</th>
<th align="center">Spike<sup>WT</sup>/Biliverdin</th>
<th align="center">Spike<sup>N121Q</sup>/Biliverdin</th>
<th align="center">Spike<sup>R190K</sup>/Biliverdin</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">&#x394;<italic>E</italic>
<sub>vdw</sub>
</td>
<td align="center">&#x2212;49.74&#xa0;&#xb1;&#xa0;2.26</td>
<td align="center">&#x2212;51.13&#xa0;&#xb1;&#xa0;2.69</td>
<td align="center">&#x2212;47.41&#xa0;&#xb1;&#xa0;2.71</td>
</tr>
<tr>
<td align="left">&#x394;<italic>E</italic>
<sub>ele</sub>
</td>
<td align="center">&#x2212;93.82&#xa0;&#xb1;&#xa0;13.25</td>
<td align="center">&#x2212;116.72&#xa0;&#xb1;&#xa0;13.73</td>
<td align="center">&#x2212;79.64&#xa0;&#xb1;&#xa0;13.34</td>
</tr>
<tr>
<td align="left">&#x394;<italic>G</italic>
<sub>GB</sub>
</td>
<td align="center">117.03&#xa0;&#xb1;&#xa0;11.08</td>
<td align="center">139.95&#xa0;&#xb1;&#xa0;11.81</td>
<td align="center">103.19&#xa0;&#xb1;&#xa0;11.71</td>
</tr>
<tr>
<td align="left">&#x394;<italic>G</italic>
<sub>SA</sub>
</td>
<td align="center">&#x2212;6.43&#xa0;&#xb1;&#xa0;0.45</td>
<td align="center">&#x2212;6.27&#xa0;&#xb1;&#xa0;0.68</td>
<td align="center">&#x2212;6.31&#xa0;&#xb1;&#xa0;0.54</td>
</tr>
<tr>
<td align="left">T&#x394;<italic>S</italic>
</td>
<td align="center">&#x2212;14.35&#xa0;&#xb1;&#xa0;3.14</td>
<td align="center">&#x2212;15.72&#xa0;&#xb1;&#xa0;3.25</td>
<td align="center">&#x2212;14.78&#xa0;&#xb1;&#xa0;3.16</td>
</tr>
<tr>
<td align="left">&#x394;<italic>G</italic>
<sub>bind</sub>
</td>
<td align="center">&#x2212;18.60&#xa0;&#xb1;&#xa0;3.52</td>
<td align="center">&#x2212;18.45&#xa0;&#xb1;&#xa0;3.25</td>
<td align="center">&#x2212;15.39&#xa0;&#xb1;&#xa0;3.76</td>
</tr>
<tr>
<td align="left">K<sub>d</sub> (nM) (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>)</td>
<td align="center">9.8</td>
<td align="center">16,800</td>
<td align="center">1,500</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>To further investigate detailed binding modes between biliverdin and the SARS-CoV-2 spike, MM/GBSA free energy decomposition analysis that decomposes the total binding free energies into ligand&#x2013;residue pairs is carried out accordingly. Eight residues, Asn121, Val126, Phe175, Met177, Arg190, Phe192, His207, and Leu226, play a dominant role in biliverdin binding, among which the side chain of Asn121 forms a hydrogen bond with biliverdin (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). However, although the amino acid in position 121 mutated from asparagine to glutamine in Spike<sup>N121Q</sup>/Biliverdin, the side chain of Gln121 can still form a hydrogen bond with biliverdin although its contribution to the binding free energy changes slightly (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). The binding pose of biliverdin in the Spike<sup>N121Q</sup>/Biliverdin changes greatly compared with the one in the Spike<sup>WT</sup>/Biliverdin. To be specific, biliverdin tends to approach His207 and away from Val126 since the length of the side chain at position 121 would become longer when the asparagine mutates to glutamine. In order to form the hydrogen bond, the biliverdin extends outside and deflects accordingly, whose dynamic procedure will be introduced in the following hydrogen bond analysis on the &#x201c;gate&#x201d; loop. For the Spike<sup>R190K</sup>/Biliverdin (<xref ref-type="fig" rid="F3">Figure&#x20;3C</xref>), its binding mode is similar to the Spike<sup>WT</sup>/Biliverdin as the same amino acids contribute to the binding free energy. However, the contributions of Lys190 and Arg102 drop from &#x2212;1.37 to &#x2212;0.31&#xa0;kcal/mol and from &#x2212;1.58 to &#x2212;0.70&#xa0;kcal/mol, respectively.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Residues around biliverdin and MM/GBSA decomposition results of the total binding free energies per residue for <bold>(</bold>
<bold>A</bold>
<bold>)</bold> Spike<sup>WT</sup>/Biliverdin, <bold>(</bold>
<bold>B</bold>
<bold>)</bold> Spike<sup>N121Q</sup>/Biliverdin, and <bold>(</bold>
<bold>C</bold>
<bold>)</bold> Spike<sup>R190K</sup>/Biliverdin.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Uncover the Possible Molecular Mechanisms of Two Single-Site Mutations on the Binding Interaction Between the SARS-CoV-2 Spike and Biliverdin</title>
<p>To further investigate how the N121Q mutant affects biliverdin binding affinity, we draw attention to hydrogen bonds around residue 121 in all three systems. In Spike<sup>WT</sup>/Biliverdin, one hydrogen bond is formed between the residue Asn121 and biliverdin. The side chain benzene ring of Phe175 can have a relative harmony &#x3c0;-&#x3c0; stack interaction with biliverdin (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). After residue Asn121 mutates into Gln121, however, as the residue Gln121&#x20;side-chain elongates while the hydrogen bond between Gln121 and the biliverdin remains, the steric hindrance is generated between the side chains of Gln121 and Phe175, which makes the Phe175 side chain benzene ring deflect outward (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). With two carboxyl groups exposed to the solvent, the biliverdin tends to move outward as the entire gate loop moves downward, narrowing the biliverdin binding pocket. Similar to that in Spike<sup>WT</sup>/Biliverdin, the gate loop does not change since the side chain benzene ring of residue Phe175 does not deflect in Spike<sup>R190K</sup>/Biliverdin (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). To further verify the deflection process, we measure the distances between the CZ atom of Phe175 and the CG atom of Asn121 (or CD atom for the case of Gln121) (<xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>). It is not hard to find that for Spike<sup>N121Q</sup>/Biliverdin, the distance increased to 7.5&#xa0;&#xc5; in a short time while the distances of the other two systems remained at 4.5&#xa0;&#xc5;, which means that the deflection of Phe175 occurred very soon after the beginning of the dynamics simulation. The N121Q mutant likely leads the biliverdin binding as a differential pose when concerning the wild-type state. In other words, to counteract the unfavorable factor from the deflection of Phe175, compound biliverdin tends to be in an inactive state by inducted fit. In turn, the inducted-fit effect would result in the irreducible binding affinity of biliverdin to the SpikeN121Q protein.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The binding interaction between the SARS-CoV-2 spike and biliverdin in <bold>(</bold>
<bold>A</bold>
<bold>)</bold> Spike<sup>WT</sup>/Biliverdin, <bold>(</bold>
<bold>B</bold>
<bold>)</bold> in Spike<sup>N121Q</sup>/Biliverdin, and <bold>(</bold>
<bold>C</bold>
<bold>)</bold> in Spike<sup>R190K</sup>/Biliverdin. <bold>(</bold>
<bold>D</bold>
<bold>)</bold> The distance between the CZ atom of Phe175 and the CG atom of Asn121 (or CD atom for the case of Gln121) was measured to reveal the deflection process of Phe175.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g004.tif"/>
</fig>
<p>As mentioned above, the mutation of R190K reduced the affinities of the biliverdin to Arg102 and Lys190. To explore the molecular mechanism, we also conducted a detailed analysis of hydrogen bonds near the amino acid at position 190, and the results are shown in <xref ref-type="fig" rid="F5">Figure&#x20;5</xref>. It can be seen that in Spike<sup>WT</sup>/Biliverdin, Arg190 can form four hydrogen bonds with Asn99 and Ser94. Meanwhile, Asn121 forms one hydrogen bond with Arg102 in addition to one hydrogen bond with the compound biliverdin. According to <xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>, these two hydrogen bond networks are independent and unrelated, and the larger cavity enables the biliverdin to be deeply embedded and bound stably. In Spike<sup>R190K</sup>/Biliverdin (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>), however, Lys190 could be simultaneously integrated with Ser94, Glu96, Asn99, and Ile101, forming six hydrogen bonds in total. While the hydrogen bond between Asn121 and Arg102 continues to exist, Arg102 also forms hydrogen bonds with Asn99. Guided by Asn99 and Ile101, Lys190 is brought closer to Arg102 and Asn121, which leads to the narrow cavity formed by these amino acids and is not conducive to the compound biliverdin insertion, widening the distances between biliverdin and Ile101 as well as Lys190 and reducing their respective energy contributions.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Hydrogen bond analysis around the amino acid at position 190 in the Spike<sup>WT</sup>/Biliverdin <bold>(</bold>
<bold>A</bold>
<bold>)</bold> and Spike<sup>R190K</sup>/Biliverdin <bold>(</bold>
<bold>B</bold>
<bold>)</bold>. Three different colors, red, green, and black, representing strong, moderate, and weak hydrogen bond interactions, were applied according to their probability range of &#x3e;80%, 60%&#x2013;80%, and 30%&#x2013;60%, respectively.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g005.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Effect of Two Single-Site Mutations on the Conformations of &#x201c;Lip&#x201d; and &#x201c;Gate&#x201d; by Hydrogen Bond Analysis</title>
<p>Previous research (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>) has already validated that the antibody binding to the SARS-CoV-2 spike NTD is inhibited by biliverdin <italic>via</italic> an allosteric mechanism which is associated with two loop regions of &#x201c;lip&#x201d; and &#x201c;gate&#x201d;. It will be meaningful to study the possible conformation of both the two loop regions in Spike<sup>WT</sup>/Biliverdin and the two mutants. Thus, hydrogen bond analyses were conducted on the two loops based on the last 100&#xa0;ns trajectories (<xref ref-type="sec" rid="s9">Supplementary Table S1</xref>). The cutoff length value of forming hydrogen bonds is set at 3&#xa0;&#xc5;. For a clearer observation, three different colors, red, green, and black, representing strong, moderate, and weak hydrogen bond interactions, respectively, were applied according to their probability range of &#x3e;80%, 60%&#x2013;80%, and 30%&#x2013;60%, respectively.</p>
<p>After observing three systems overlapping together (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>), it can be concluded that two single-site mutations have posed significant changes to the lip region. As for the lip of Spike<sup>WT</sup>/Biliverdin (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref> and <xref ref-type="sec" rid="s10">Supplementary Figure S1A</xref>), one strong hydrogen bond is formed between His146 and Ser151, and five moderate hydrogen bonds are formed between Met153 and Tyr144 (two hydrogen bonds are formed), Gly142 and Ser155, Val143 and Arg246, and Leu244 and Val143 while Arg102 and Glu154 form four weak hydrogen bonds. Concerning Spike<sup>N121Q</sup>/Biliverdin (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>), the advent of residues Leu244 and Arg246 resulted in a new hydrogen bond formed each with Val143 and Tyr144, leading to the loop<sub>244-261</sub> approaching the lip (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref> and <xref ref-type="sec" rid="s10">Supplementary Figure S1B</xref>). Moreover, compared with Spike<sup>N121Q</sup>/Biliverdin, new hydrogen bonds form between Asn122 and Glu154, Ala123 and Glu154, Ser254 and Tyr144, and Leu249 and Lys147 in the Spike<sup>R190K</sup>/Biliverdin (<xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>); it reveals that not only loop<sub>244-261</sub> but also loop<sub>122-123</sub> interacts with the lip (<xref ref-type="sec" rid="s10">Supplementary Figure S1C</xref>). The stabilized lip is likely to exist in two mutated systems, which would restrain the meaningful upward movement of the lip as discussed in previous literature (<xref ref-type="bibr" rid="B18">Rosa et&#x20;al., 2021</xref>), ultimately interfering with the antibody fixing on the SARS-CoV-2&#x20;spike.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Three different colors, red, green, and black, representing strong, moderate, and weak hydrogen bond interactions, were applied according to their probability range of &#x3e;80%, 60%&#x2013;80%, and 30%&#x2013;60%, respectively. <bold>(</bold>
<bold>A</bold>
<bold>)</bold> Comparison of the lip loops in three systems. <bold>(</bold>
<bold>B</bold>
<bold>)</bold> Illustration of the hydrogen bond interaction of the lip in Spike<sup>WT</sup>/Biliverdin, <bold>(</bold>
<bold>C</bold>
<bold>)</bold> in Spike<sup>N121Q</sup>/Biliverdin, and <bold>(</bold>
<bold>D</bold>
<bold>)</bold> in Spike<sup>R190K</sup>/Biliverdin.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g006.tif"/>
</fig>
<p>The possible conformation changes of the gate loop derived from two mutants were also studied (<xref ref-type="fig" rid="F7">Figure&#x20;7</xref>). It is not hard to find that the N121Q mutation had the N-terminal residues of the gate (residues 175 to 178) dramatically changed in contrast to the other two systems (<xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>). The hydrogen bond network of the Spike<sup>WT</sup>/Biliverdin system is characterized by one strong hydrogen bond formed between Asn188 and Glu96, two moderate ones formed between Glu96 and Lys187 and between Phe175 and Thr124, and another three weak hydrogen bonds (<xref ref-type="fig" rid="F7">Figure&#x20;7B</xref>). Intriguingly, a strong Asn99&#x2013;Asp178 hydrogen bond is formed in Spike<sup>N121Q</sup>/Biliverdin (<xref ref-type="fig" rid="F7">Figure&#x20;7C</xref>), which triggers the gate loop approaching and narrowing the binding pocket of the biliverdin. As for Spike<sup>R190K</sup>/Biliverdin (<xref ref-type="fig" rid="F7">Figure&#x20;7D</xref>), an additional moderate hydrogen bond is formed by Asn185 and Asn211 to stabilize the similar gate conformation in Spike<sup>WT</sup>/Biliverdin.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Three different colors, red, green, and black, representing strong, moderate, and weak hydrogen bond interactions, were applied according to their probability range of &#x3e;80%, 60%&#x2013;80%, and 30%&#x2013;60%, respectively. <bold>(</bold>
<bold>A</bold>
<bold>)</bold> Comparison of the gate loops in three systems. Illustration of hydrogen bond interaction of the lip <bold>(</bold>
<bold>B</bold>
<bold>)</bold> in Spike<sup>WT</sup>/Biliverdin, <bold>(</bold>
<bold>C</bold>
<bold>)</bold> in Spike<sup>N121Q</sup>/Biliverdin, and <bold>(</bold>
<bold>D</bold>
<bold>)</bold> in Spike<sup>R190K</sup>/Biliverdin.</p>
</caption>
<graphic xlink:href="fmolb-08-791885-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>The global spread of the novel coronavirus disease 2019 (COVID-19), one of the deadliest pandemics in modern history, has been unprecedented since it first emerged. The SARS-CoV-2 spike is currently the main target of antibody design. Previous studies have reported the crystal structure of the SARS-CoV-2 spike and biliverdin and have come up with the idea that two single-site mutations, R190K and N121Q, will weaken the binding affinity of the biliverdin although the potential molecular mechanism is still unknown. As a result, this project studied the WT and two other mutants of the SARS-CoV-2 spike, employing MD simulation and MM/GBSA free energy calculation. Our simulations confirmed that the R190K mutation causes amino acid 190 to form six hydrogen bonds with surrounding residues Ser94, Glu96, Asn99, and Ile101, which, guided by Asn99 and Ile101, brings Lys190 closer to Arg102 and Asn121, thereby weakening the interaction energy between biliverdin and Ile101 as well as Lys190. However, in the case of N121Q mutation, although Q121 still maintained hydrogen bond interaction with biliverdin, the overall binding mode deviated significantly under the reversal of the benzene ring of the Phe175 side chain compared with WT. Moreover, we found that R190K and N121Q mutants would stabilize the lip loop. The stabilized lip was likely to exist in two mutated systems, which would restrain the meaningful upward movement of the lip, ultimately interfering with the antibody fixing on the SARS-CoV-2 spike. In addition, N121Q significantly promoted the gate loop deviating to the biliverdin binding site and compressed the site so that biliverdin could not maintain the binding mode of WT. However, the R190K mutation had little influence on the gate loop and could also make the structural change of the gate loop similar to WT. Studying the interaction between the SARS-CoV-2 spike and the biliverdin and two single-site mutations using simulation methods, we hope, will support future antibody research targeting the SARS-COV-2&#x20;spike.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>Conceptualization, JG and ZQ; methodology, ZQ, KL and XG; data curation, ZQ and XG; writing&#x2014;original draft preparation, ZQ and BH; writing&#x2014;review and editing, JG and ZQ; visualization, ZQ; project administration, JG; funding acquisition, JG. All authors have read and agreed to the published version of the manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This research was funded by the Natural Science Foundation of Jiangsu Province (grant number BK20201157), the Six Talent Peaks Project in Jiangsu Province (grant number YY-046), and the Qinglan Project of Jiangsu Province of China to&#x20;JG.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>JG was employed by the company Xuzhou Medical University Technology Transfer Center Co.,&#x20;Ltd.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.791885/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2021.791885/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Discovery of Small Molecule Sirt1 Activator Using High-Throughput Virtual Screening, Molecular Dynamics Simulation, Molecular Mechanics Generalized Born/surface Area (MM/GBSA) Calculation, and Biological Evaluation</article-title>. <source>Med. Chem. Res.</source> <volume>29</volume>, <fpage>255</fpage>&#x2013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1007/s00044-019-02479-2</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Case</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Cheatham</surname>
<given-names>T. E.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Darden</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gohlke</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Merz</surname>
<given-names>K. M.</given-names>
<suffix>Jr.</suffix>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>The Amber Biomolecular Simulation Programs</article-title>. <source>J.&#x20;Comput. Chem.</source> <volume>26</volume>, <fpage>1668</fpage>&#x2013;<lpage>1688</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20290</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019a</year>). <article-title>Assessing the Performance of Three Resveratrol in Binding with SIRT1 by Molecular Dynamics Simulation and MM/GBSA Methods: the Weakest Binding of Resveratrol 3 to SIRT1 Triggers a Possibility of Dissociation from its Binding Site</article-title>. <source>J.&#x20;Comput. Aided Mol. Des.</source> <volume>33</volume>, <fpage>437</fpage>&#x2013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-019-00193-0</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019b</year>). <article-title>Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>20</volume>, <fpage>5410</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20215410</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A Neutralizing Human Antibody Binds to the N-Terminal Domain of the Spike Protein of SARS-CoV-2</article-title>. <source>Science</source> <volume>369</volume>, <fpage>650</fpage>&#x2013;<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1126/science.abc6952</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>A point-charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-phase Quantum Mechanical Calculations</article-title>. <source>J.&#x20;Comput. Chem.</source> <volume>24</volume>, <fpage>1999</fpage>&#x2013;<lpage>2012</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.10349</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Frisch</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Trucks</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Schlegel</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Scuseria</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Robb</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Cheeseman</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <source>Expanding the Limits of Computational Chemistry</source>. <publisher-loc>Wallingford Ct</publisher-loc>: <publisher-name>Gaussian, Inc.</publisher-name> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genheden</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ryde</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The MM/PBSA and MM/GBSA Methods to Estimate Ligand-Binding Affinities</article-title>. <source>Expert Opin. Drug Discov.</source> <volume>10</volume>, <fpage>449</fpage>&#x2013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1517/17460441.2015.1032936</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Seow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huettner</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kouphou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Acors</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Neutralization Potency of Monoclonal Antibodies Recognizing Dominant and Subdominant Epitopes on SARS-CoV-2 Spike Is Impacted by the B.1.1.7 Variant</article-title>. <source>Immunity</source> <volume>54</volume>, <fpage>1276</fpage>&#x2013;<lpage>1289</lpage>. <comment>e1276</comment>. <pub-id pub-id-type="doi">10.1016/j.immuni.2021.03.023</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wujieti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.-Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Insight into the Drug Resistance Mechanisms of GS-9669 Caused by Mutations of HCV NS5B Polymerase <italic>via</italic> Molecular Simulation</article-title>. <source>Comput. Struct. Biotechnol. J.</source> <volume>19</volume>, <fpage>2761</fpage>&#x2013;<lpage>2774</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2021.04.026</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z.-L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Characteristics of SARS-CoV-2 and COVID-19</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>19</volume>, <fpage>141</fpage>&#x2013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-020-00459-7</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Human Neutralizing Antibodies Elicited by SARS-CoV-2 Infection</article-title>. <source>Nature</source> <volume>584</volume>, <fpage>115</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2380-z</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Oton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cortese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zila</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mckeane</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Structures and Distributions of SARS-CoV-2 Spike Proteins on Intact Virions</article-title>. <source>Nature</source> <volume>588</volume>, <fpage>498</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2665-2</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kemp</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Datir</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>I. A. T. M.</given-names>
</name>
<name>
<surname>Gayed</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jahun</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SARS-CoV-2 Evolution during Treatment of Chronic Infection</article-title>. <source>Nature</source> <volume>592</volume>, <fpage>277</fpage>&#x2013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03291-y</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kollman</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Massova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models</article-title>. <source>Acc. Chem. Res.</source> <volume>33</volume>, <fpage>889</fpage>&#x2013;<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1021/ar000033j</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rapp</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Potent Neutralizing Antibodies against Multiple Epitopes on SARS-CoV-2 Spike</article-title>. <source>Nature</source> <volume>584</volume>, <fpage>450</fpage>&#x2013;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2571-7</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onufriev</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bashford</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Exploring Protein Native States and Large-Scale Conformational Changes with a Modified Generalized Born Model</article-title>. <source>Proteins</source> <volume>55</volume>, <fpage>383</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1002/prot.20033</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pye</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Muir</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Seow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>K. W.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SARS-CoV-2 Can Recruit a Heme Metabolite to Evade Antibody Immunity</article-title>. <source>Sci. Adv.</source> <volume>7</volume>, <fpage>eabg7607</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abg7607</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Characterization the Performances of Twofold Resveratrol Integrated Compounds in Binding with SIRT1 by Molecular Dynamics Simulation and Molecular Mechanics/generalized Born Surface Area (MM/GBSA) Calculation</article-title>. <source>Chem. Phys.</source> <volume>544</volume>, <fpage>111108</fpage>. <pub-id pub-id-type="doi">10.1016/j.chemphys.2021.111108</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tegally</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lessells</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Giandhari</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pillay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Msomi</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Sixteen Novel Lineages of SARS-CoV-2 in South Africa</article-title>. <source>Nat. Med.</source> <volume>27</volume>, <fpage>440</fpage>&#x2013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-021-01255-3</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tregoning</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Cheeseman</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Flight</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Higham</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Lemm</surname>
<given-names>N. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Vaccines for COVID&#x2010;19</article-title>. <source>Clin. Exp. Immunol.</source> <volume>202</volume>, <fpage>162</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1111/cei.13517</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walls</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Tortorici</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mcguire</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Veesler</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</article-title>. <source>Cell</source> <volume>181</volume>, <fpage>281</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kollman</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations</article-title>. <source>J.&#x20;Mol. Graphics Model.</source> <volume>25</volume>, <fpage>247</fpage>&#x2013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2005.12.005</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Kollman</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Development and Testing of a General Amber Force Field</article-title>. <source>J.&#x20;Comput. Chem.</source> <volume>25</volume>, <fpage>1157</fpage>&#x2013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20035</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M.-Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.-J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.-F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.-P.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.-M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development</article-title>. <source>Front. Cel. Infect. Microbiol.</source> <volume>10</volume>, <fpage>587269</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.587269</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wrapp</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Goldsmith</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Abiona</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation</article-title>. <source>Science</source> <volume>367</volume>, <fpage>1260</fpage>&#x2013;<lpage>1263</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zost</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Gilchuk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Binshtein</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Nkolola</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Potently Neutralizing and Protective Human Antibodies against SARS-CoV-2</article-title>. <source>Nature</source> <volume>584</volume>, <fpage>443</fpage>&#x2013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2548-6</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>